What is CNE?
We are dedicated to changing the brain cancer narrative.
The Consortium for Neuro-Oncology Excellence (CNE) is a collaborative effort harnessing expertise across every key discipline within the Australian neuro-oncology space. The experience of CNE’s members include that of oncology, neurosurgery, radiation oncology, translational science, genomics, oncology diagnostics, immuno-oncology, biobanking and drug discovery.
CNE aims to utilise these interconnected disciplines to facilitate new and innovative research projects and clinical trials. We have the existing infrastructure, resources and expertise to finally make a difference for patients and their families.
Our Mission
-
Clinical Trial Excellence
To coordinate effective and innovative brain cancer research projects and clinical trials that specifically address key disease obstacles.
-
Improve Patient Outcomes
To make available novel and safe therapeutic interventions for those diagnosed with brain cancer, elevating the quality of standards of care.
-
Strength Through Collaboration
To develop a strong, collaborative brain cancer clinical and scientific network to harness the power of shared resources and infrastructure.
-
Raise Awareness
To continue raising the profile of brain cancer within the wider community, ensuring it receives the attention and funding required to make progress.